Most common were delayed large local reactions, followed by local injection site reactions, urticarial eruptions, morbilliform eruptions
MONDAY, April 12, 2021 (HealthDay News) — Skin reactions can occur following COVID-19 vaccination, but reactions are mild, according to a study published online April 7 in the Journal of the American Academy of Dermatology.
Devon E. McMahon, from Harvard Medical School in Boston, and colleagues evaluated cases of cutaneous manifestations after COVID-19 vaccination.
The researchers report that from December 2020 to February 2021, there were 414 cutaneous reactions to mRNA COVID-19 vaccines (Moderna, 83 percent; Pfizer, 17 percent). The most common manifestations were delayed large local reactions, followed by local injection site reactions, urticarial eruptions, and morbilliform eruptions. Second-dose recurrence occurred among 43 percent of patients with first-dose reactions. No patients developed adverse events after either dose.
“As dermatologists, we view the skin as a window into what is happening elsewhere in your body,” a coauthor said in a statement. “Through this research, we have a deeper understanding of how the COVID-19 vaccine affects our patients and their skin, and I hope our findings, which show that people tolerated vaccination well even when they did develop skin side effects, offer greater reassurance for anyone who is hesitant to get vaccinated.”
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions
Considerable Global Disparities Found in Access to Dermatological Care
Extreme Heat Linked to 33 Clinically Reportable Diagnoses
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes
Therapist-Led Online Cognitive Behavioral Therapy Aids Depression
Short-Term Pretransplant Dialysis Does Not Affect Kidney Transplant Outcomes